Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CARotid plaqUe StabilizatiOn and Regression With Evolocumab: the CARUSO Study

NCT04730973 is registered in ClinicalTrials.gov with Azienda Ospedaliera Ordine Mauriziano di Torino as lead sponsor.

NCT NCT04730973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04730973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CARotid plaqUe StabilizatiOn and Regression With Evolocumab: the CARUSO Study
Lead sponsor
Azienda Ospedaliera Ordine Mauriziano di Torino
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2021
Completion date
March 31, 2022
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carotid artery disease